Your browser is no longer supported. Please, upgrade your browser.
AGN Allergan plc daily Stock Chart
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-3.12 Insider Own0.10% Shs Outstand374.44M Perf Week-0.63%
Market Cap91.88B Forward P/E13.82 EPS next Y17.76 Insider Trans1.68% Shs Float374.18M Perf Month14.89%
Income-1219.50M PEG- EPS next Q3.39 Inst Own82.60% Short Float4.27% Perf Quarter29.94%
Sales14.57B P/S6.31 EPS this Y63.30% Inst Trans-7.83% Short Ratio3.97 Perf Half Y0.86%
Book/sh221.28 P/B1.11 EPS next Y10.86% ROA- Target Price268.74 Perf Year-17.20%
Cash/sh35.32 P/C6.95 EPS next 5Y13.31% ROE- 52W Range184.50 - 301.32 Perf YTD16.84%
Dividend2.80 P/FCF- EPS past 5Y-28.70% ROI- 52W High-18.57% Beta1.15
Dividend %1.14% Quick Ratio- Sales past 5Y26.00% Gross Margin87.20% 52W Low32.99% ATR4.96
Employees31200 Current Ratio- Sales Q/Q7.10% Oper. Margin-12.50% RSI (14)72.42 Volatility1.28% 2.47%
OptionableYes Debt/Eq- EPS Q/Q85.70% Profit Margin- Rel Volume0.46 Prev Close247.03
ShortableYes LT Debt/Eq- EarningsFeb 08 BMO Payout0.00% Avg Volume4.03M Price245.37
Recom2.00 SMA203.88% SMA5012.12% SMA2007.80% Volume1,838,042 Change-0.67%
Feb-09-17Reiterated Mizuho Buy $273 → $275
Dec-09-16Reiterated Credit Suisse Outperform $301 → $274
Nov-17-16Reiterated Mizuho Buy $293 → $273
Nov-03-16Reiterated RBC Capital Mkts Outperform $300 → $279
Nov-01-16Reiterated Mizuho Buy $299 → $293
Oct-31-16Resumed Barclays Equal Weight $250
Oct-11-16Reiterated Mizuho Buy $305 → $299
Aug-19-16Upgrade Mizuho Neutral → Buy $248 → $318
Aug-09-16Reiterated RBC Capital Mkts Outperform $307 → $300
Aug-09-16Reiterated Deutsche Bank Buy $282 → $278
Aug-05-16Reiterated Mizuho Neutral $232 → $246
Jul-27-16Reiterated Leerink Partners Outperform $272 → $294
Jul-25-16Initiated Credit Suisse Outperform $327
May-13-16Reiterated Mizuho Neutral $250 → $232
Apr-18-16Resumed Goldman Buy $275
Apr-18-16Initiated Guggenheim Neutral
Apr-18-16Downgrade Piper Jaffray Overweight → Neutral $311 → $238
Apr-07-16Resumed Morgan Stanley Overweight $300
Apr-07-16Resumed JP Morgan Overweight
Apr-07-16Reiterated UBS Buy $366 → $300
Feb-24-17 05:13PM  ALLERGAN PLC Files SEC form 10-K, Annual Report
01:21PM  NASH Is Todd Hagopian's Top Biotech Sub-Sector For 2017 at Forbes
10:58AM  Top Research Reports for February 24, 2017
Feb-23-17 05:15PM  Eli Lilly & Co.s Revenues in 4Q16
09:41AM  Pernix Therapeutics surges 42% after patent case win against generic from Actavis Labs at MarketWatch
Feb-22-17 09:14PM  Allergan CEO Pushes for Trump to Lead Drug Price Discussions
10:34AM  Ironwood (IRWD) Q4 Loss Narrower than Expected; Sales Top
08:01AM  Allergan to Sponsor Alzheimer's Foundation of America '15th Anniversary National Educating America' Tour PR Newswire
Feb-21-17 10:58AM  Medtronic Earnings Rebound in Third Quarter, Shares Climb
09:30AM  The Zacks Analyst Blog Highlights: Merck, Valeant Pharmaceuticals International, Allergan, AstraZeneca and Johnson & Johnson
12:01AM  [$$] Big pharma bets billions on 'silent' liver disease at Financial Times
Feb-17-17 09:00PM  Riddle Me This; Bendable Market: Best of Kass
05:15PM  Stull, Stull & Brody is Investigating Claims on Behalf of Allergans (NYSE:AGN) 401(k) Plan GlobeNewswire
04:22PM  Deals of the Week: Valentine Couplings and Breakups
07:21AM  Pharma Stock Roundup: Merck's Alzheimer's Study Halted, Allergan to Buy ZELTIQ
Feb-16-17 06:55PM  Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks at Motley Fool
05:38PM  Stress boom to boost drug sales?
12:06PM  David Tepper Invests Heavily in Pharma in 4th Quarter
Feb-15-17 03:03PM  5 Ways Allergan Can Keep Up Momentum
02:54PM  Tepper's Appaloosa Fund Continues Bet on Drug Companies in Q4 2016 at Investopedia
02:18PM  Tepper's Appaloosa triples stake in Allergan
01:24PM  Billionaire Dan Loebs Biggest Q4 Moves Include Bank-Buying Spree, Selling Allergan (AGN) at Insider Monkey
07:00AM  Medicines360 And Allergan Announce Partnership With Health Centers To Help Address Unintended Pregnancies In Areas Impacted By Zika PR Newswire
Feb-14-17 05:52PM  What the Smart Money's buying
05:32PM  David Tepper Increases Wagers on Drug Companies at The Wall Street Journal
05:22PM  Bets on financials, pharma power U.S. hedge funds' strong start to year Reuters
05:19PM  David Tepper's Appaloosa just dropped about $1 billion on 4 pharma stocks
04:54PM  Appaloosa Management snaps up Allergan shares in 4th quarter at MarketWatch
04:09PM  Hologic Follows Allergan, Buying Body-Sculptor Cynosure For $1.65 Bil
03:37PM  Sachem Head's Ferguson to exit Autodesk board, fund gains -letter
02:13PM  ETFs with exposure to Allergan Plc : February 14, 2017
09:45AM  Today's Research Reports on Stocks to Watch: Teva Pharmaceutical Industries and Allergan Accesswire
09:24AM  Valeant, Pershing Square to Split Legal Fees on Allergan Lawsuit
08:20AM  Teva (TEVA) Tops on Q4 Earnings, Maintains 2017 Guidance
08:15AM  Blog Coverage Allergan Acquires ZELTIQ; Set to Expand Presence in the Body Contouring Business Accesswire
07:07AM  Botox-maker Allergan is betting that zapping your fat is worth $4 billion at MarketWatch
06:26AM  New Relic: Cramer's Top Takeaways
Feb-13-17 11:48PM  Asian shares fall back as investors await comments by Yellen
05:57PM  Allergan Paying Nearly $2.5 Billion for ZELTIQ at Investopedia
05:30PM  Daniel Loeb Picks Up Rate-Sensitive Financials, Drops Pharma
05:18PM  Allergan Plc -- Moody's: Allergan's ZELTIQ acquisition credit negative on high pricetag at Moody's
05:11PM  Allergan To Acquire ZELTIQ in $2.47 Billion Deal, ZELTIQ Shares Pop 13%
04:51PM  Zeltiq, US Steel and Chemours rise; Hain Celestial plunges
04:40PM  Why Chemours, Zeltiq Aesthetics, and Vale Jumped Today at Motley Fool
04:34PM  Allergan to buy fat-fighter Zeltiq Aesthetics for $2.48 bln
04:05PM  Allergan To Buy Fat-Freezing Zeltiq For $2.5 Bil; Zeltiq Hits Record High
04:00PM  STOCKS HIT ALL-TIME HIGHS: Here's what you need to know
02:24PM  Allergan Acquires Zeltiq Aesthetics for $2.48 Billion at Investopedia
01:26PM  How to Trade Monday's Most Active Stocks: BofA, Vale, Zeltiq, Teva and More
01:15PM  Allergan Acquires ZELTIQ For $2.47 Billion at Investopedia
12:56PM  Why Zeltiq Aesthetics Stock Is Surging Higher Today at Motley Fool
12:12PM  Allergan Shares Surge After Announcing Acquisition of Zeltiq Aesthetics at TheStreet
11:21AM  [$$] Allergan agrees to buy fat-freezing company for $2.47bn at Financial Times
11:11AM  [video]Allergan Shares Rise on $2.5B Deal for Body-Sculptor Zeltiq
11:00AM  Stocks Trade Above Record Closes, Apple Nears All-Time High
10:53AM  UPDATE 2-Allergan to buy Zeltiq Aesthetics for about $2.48 bln
10:31AM  Teva seeks CEO with pharma background to lead recovery efforts Reuters
09:39AM  Morning Movers: Verizon Falls, Teva Jumps, Hain Celestial Craters at
09:34AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of ZELTIQ Aesthetics, Inc. to Allergan plc for $56.50 Per Share is Fair to Shareholders - ZLTQ Accesswire
09:32AM  [$$] Allergan to Buy Fat-Treatment Maker Zeltiq for $2.3 Billion at The Wall Street Journal
09:31AM  Verizon unlimited data is back, Burger King parent Restaurant Brands boosts profit, Allergan buys fat treatment company
08:51AM  Allergan to spend $2.48 B on CoolSculpting provider Zeltiq
08:15AM  Allergan to acquire body contouring company Zeltiq Aesthetics for $2.5 billion at MarketWatch
08:12AM  Allergan is buying a fat-freezing company for $2.5 billion
08:08AM  Allergan agrees to buy Zeltiq for about $2.48 bln
08:00AM  Allergan to Acquire ZELTIQ, Best-in-Class Company in Fast-Growing Body Contouring Segment, for $2.47 Billion PR Newswire
07:45AM  Early movers: AAPL, DD, TEVA, QSR, FDC, HAS, JCP & more at CNBC
05:00AM  [$$] SEC Letter to Allergan Hints at Additional non-GAAP Guidance at The Wall Street Journal
Feb-10-17 07:11PM  Cramer's Exec Cut: Why GE isnt worried about Trumps tra...
07:01PM  Cramer: Why Are People Dumping Such Good Stocks?
05:02PM  Dan Loeb took new stakes in J.P. Morgan, B. of A. and dumped Allergan at MarketWatch
04:10PM  Intercept Bounds To 3-Month High On NASH Trial Edits; Analysts Split
12:02PM  Allergan Plc :AGN-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
06:44AM  Pharma Stock Roundup: Allergan, GSK Top 4Q Earnings, Praluent Breather for Sanofi
Feb-09-17 04:15PM  Allergan to Present at The Leerink Partners 6th Annual Global Healthcare Conference PR Newswire
12:45PM  Cramer: Here's the Reason for Allergan's Remarkable Run
12:00PM  AASLD Foundation's Liver Disease Research and Education Initiatives Bolstered by Significant Donation from Allergan PR Newswire
10:10AM  Company News for February 09, 2017
09:40AM  Allergan Plc :AGN-US: Earnings Analysis: Q4, 2016 By the Numbers : February 9, 2017
09:30AM  Today's Research Reports on Gilead Sciences and Allergan Post Earnings Accesswire
08:43AM  How To Invest Like Seth Klarman
06:23AM  Allergan: Cramer's Top Takeaways
Feb-08-17 07:34PM  Cramer Remix: Why you would be an idiot to sell Disney at CNBC
07:18PM  Cramer Remix: The reason you would be an idiot to sell Di...
06:31PM  Is This Market in Trump-Bubble Territory? Cramer's 'Mad Money' Recap (Wednesday 2/8/17)
04:21PM  Allergan Leads Drug Stocks On View-Crushing Q4, 2016, 2017 Guidance
04:01PM  What's Next For Allergan? How About More Acquisitions and a Dividend! at
03:17PM  Allergan PLC (AGN) Launches Campaign To Fight Preventable Blindness In America at Insider Monkey
03:09PM  Edited Transcript of AGN earnings conference call or presentation 8-Feb-17 1:30pm GMT
12:29PM  Allergan's Fourth-Quarter Comments Should Comfort Investors
12:17PM  Allergan says U.S. tax reform unlikely in 2017, sees strong year
11:39AM  Botox Smooths Out Allergan Top and Bottom Line at Investopedia
11:28AM  Stocks Turn Mixed as Oil Prices Rebound, Disney Jumps
11:09AM  [$$] Allergan Results Boosted by New, Established Drugs at The Wall Street Journal
10:39AM  Allergan Tops Revenue Forecast -- Plus Jim Cramer's Comments
09:57AM  Allergan (AGN) Tops Q4 Earnings; 2017 Sales View Upbeat
09:54AM  Cramer's Stop Trading: AGN
09:12AM  Market Recon: The Direction of Oil Has Been Somewhat Shocking
09:05AM  Allergan (AGN) Beats Q4 Earnings & Sales; Shares Up
08:30AM  Allergan plc Earnings Call scheduled for 8:30 am ET today
Allergan plc, a specialty pharmaceutical company, develops, manufactures, markets, and distributes medical aesthetics, biosimilar, and over-the-counter pharmaceutical products worldwide. It operates through US Brands, US Medical Aesthetics, International Brands, and Anda Distribution segments. The company offers a portfolio of products that provide treatments for the central nervous system, gastroenterology, women's health and urology, ophthalmology, neurosciences, medical aesthetics, liver disease, inflammation, fibrosis, and HIV, as well as dermatology and plastic surgery, and Alzheimer's disease. It is also involved in developing ocular implants that reduce intraocular pressure associated with glaucoma; medical devices for the correction of prominent ears; and intranasal neurostimulation devices, as well as other dry eye products. In addition, it distributes generic and branded pharmaceutical products primarily to independent pharmacies, pharmacy chains, pharmacy buying groups, and physicians' offices. Further, the company develops, processes, and markets tissue-based products for use in reconstructive, orthopedic, and urogynecologic surgical procedures to repair soft tissue defects. Allergan plc has a collaboration with T2 Biosystems to develop blood-based diagnostic panel for the detection of Gram-negative bacterial species. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Meury WilliamChief Commercial OfficerDec 08Option Exercise109.1211,8071,288,38048,866Feb 14 09:13 PM
Basgoz NesliDirectorDec 08Sale188.7250094,3605,515Dec 09 05:56 PM
SAUNDERS BRENT LCEO and PresidentNov 21Buy189.135,250992,941106,564Nov 21 04:03 PM
Hilado Maria TeresaChief Financial OfficerNov 11Buy210.641,422299,53613,379Nov 15 05:18 PM